<--- Back to Details
First PageDocument Content
Aspergillus fumigatus / Aspergillus / Virulence factor / Pathogenic fungi / Allergic bronchopulmonary aspergillosis / Cell wall / Virulence / Melanin / Beta-glucan / Biology / Fungal diseases / Microbiology
Date: 2012-02-29 17:36:13
Aspergillus fumigatus
Aspergillus
Virulence factor
Pathogenic fungi
Allergic bronchopulmonary aspergillosis
Cell wall
Virulence
Melanin
Beta-glucan
Biology
Fungal diseases
Microbiology

Rev Iberoam Micol. 2010;27(4):155–182 Revista Iberoamericana

Add to Reading List

Source URL: www.reviberoammicol.com

Download Document from Source Website

File Size: 1,20 MB

Share Document on Facebook

Similar Documents

Seminar Announcement Localized Virulence Factor Assembly in Enterococcus faecalis Date: 18 March 2016 Friday

DocID: 1uIDj - View Document

3 學 術 幽門螺旋桿菌導致胃黏膜傷害的免疫致病機轉 ~由細菌毒力因子(Virulence Factor)談起

DocID: 1tcoQ - View Document

Percolozoa / Microbiology / Biology / Antonie van Leeuwenhoek / Naegleriasis / Naegleria fowleri / Naegleria / Meningoencephalitis / Schizopyrenida / Amoeba / Virulence / Protozoa

A collaboration between the Spiez Laboratory, Federal Office for Civil Protection, and the Institute of Parasitology of the University of Bern Genomic, transcriptomic and proteomic identification of pathogenicity factor

DocID: 1qN1w - View Document

Escherichia coli / Medicine / Microbiology / Clinical medicine / Escherichia coli O157:H7 / Escherichia coli O121 / Shiga toxin / Virulence factor / Colitis / Intimin / Virulence / Shigatoxigenic and verotoxigenic Escherichia coli

Non-O157 Shiga Toxin Producing Escherichia coli (STEC) Workshop RESEARCH RKM

DocID: 1qp4M - View Document

Bacterial diseases / Pathogenic bacteria / Bacteriology / Microbiology / Healthcare-associated infections / Antimicrobial resistance / Staphylococcus aureus / Antibiotics / Bacteria / Infection / Virulence factor / Virulence

Positive Preclinical Efficacy data for LASCCO’s CAL02 Published in Nature Biotechnology nd Geneva, Switzerland, 2 November 2014 – LASCCO announces the publication of positive preclinical efficacy studies for its anti

DocID: 1pbdL - View Document